Search
for
Sort by
Research 511–540 of 554
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Glutamic acid-loaded separable microneedle composite for long-acting hair regeneration treatment
- Near-infrared light-triggered nitric oxide-releasing hyaluronic acid hydrogel for precision transdermal therapy of androgenic alopecia
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Screening of Anti-Hair Loss Plant Raw Materials Based on Reverse Network Pharmacology and Experimental Validation
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Alopecia Areata
- Dermatological Indications: Alopecia Areata
- Alopecia areata: recognition, diagnosis and management
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Injectables for Hair Loss Treatment
- ALOPECIA AREATA: ASPECTOS FISIOLÓGICOS E AVANÇOS TERAPÊUTICOS – UMA REVISÃO DE LITERATURA
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Non-Scarring Alopecia in Females: A Comprehensive Review
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Gynostemma pentaphyllum Hydrodistillate and Its Major Component Damulin B Promote Hair Growth-Inducing Properties In Vivo and In Vitro via the Wnt/β-Catenin Pathway in Dermal Papilla Cells
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Nanotechnology-based techniques for hair follicle regeneration
- Targeted immunotherapy for hair regrowth and regeneration
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials